0.66 (-%)
As of Nov 21, 2024
Source:
Gossamer Bio, Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension, or PAH.
| Country | United States |
| Headquarters | san diego, california |
| Phone Number | (858) 684-1300 |
| Industry | manufacturing |
| CEO | Faheem Hasnain |
| Website | www.gossamerbio.com |